Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2011

01-12-2011 | Colorectal Cancer

High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?

Author: Theodore Liakakos, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2011

Login to get access

Excerpt

The level of ligation of inferior mesenteric artery (IMA) in patients with colon or rectal cancer in open or laparoscopic surgery has been controversial. In a recent cross-sectional survey among high-volume surgeons, 69% perform high ligation of the IMA and 72% laparoscopic proctectomy.1 Although standardization of colorectal resection with high ligation of IMA is a safe procedure and the operating time is not longer for experienced surgeons, there has been criticism that it is an overtreatment, requires mobilization of splenic flexure to prevent risk of anastomosis, and has limited benefit in recurrence-free and overall survival. …
Literature
1.
Augestad KM, Lindsetmo RO, Reynolds H, et al. International trends in surgical treatment of rectal cancer. Am J Surg. 2011;201(3):353–7, discussion 357–8.PubMedCrossRef
2.
Kang J, Hur H, Min BS, Kim NK, Lee KY. Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol. 2011;18(3):704–10.PubMedCrossRef
3.
Alberts SR, Sargent DJ, Smyrk TC, et al. Adjuvant mFOLFOX6 with or without cetuximab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): results from NCCTG Intergroup Phase III Trial N0147. J Clin Oncol. 2010;28(18 Suppl) (Abstract CRA3507).
4.
Green ED, Guyer MS. National human genome research institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470(7333):204–13.PubMedCrossRef
5.
Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics. 2010;11(8):1039–43.PubMedCrossRef
6.
Roukos DH. Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med. 2010;4(4):583–6.PubMedCrossRef
7.
Roukos DH, Katsios C, Liakakos T. Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn. 2010;10(5):541–5.PubMedCrossRef
8.
Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10(3):247–50.PubMedCrossRef
9.
Roukos DH. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. 2011;11(2):81–92.PubMedCrossRef
10.
Roukos DH. Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices. 2010;7(6):723–6.PubMedCrossRef
11.
Katsios C, Roukos DH. Individual genomes and personalized medicine: life diversity and complexity. Per Med. 2010;7(4):347–50.CrossRef
Metadata
Title
High Ligation of Inferior Mesenteric Artery: A Standard Procedure for Colorectal Cancer?
Author
Theodore Liakakos, MD
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1883-0

Other articles of this Special Issue 3/2011

Annals of Surgical Oncology 3/2011 Go to the issue

Erratum

Erratum to: Overexpression of Renal Tumor Antigen Is Associated with Tumor Invasion and Poor Prognosis of Hepatocellular Carcinoma

Breast Oncology

Moving Away From Axillary Lymph Node Dissection Indicates Practice-Changing Trials

Colorectal Cancer

Reply about “Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer”

Head and Neck Oncology

Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer

Healthcare Policy and Outcomes

Interpretation of the C-Statistic in the Context of ACS-NSQIP Models

Erratum

Erratum to: Immediate Repair of Major Abdominal Wall Defect After Extensive Tumor Excision in Patients With Abdominal Wall Neoplasm: A Retrospective Review of 27 Cases